Warm Homes for Elder New Zealanders

Chronic Obstructive Pulmonary Disease Clinical Trial

— WHEZ  

Official title:

Warm Homes for Elder New Zealanders: a Community Trial of People With COPD

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01627418
• Other study ID #: HRC08/072AR
• Status: Completed
• Phase: N/A
• First received: August 2, 2011
• Last updated: June 15, 2015
• Start date: April 2009
• Est. completion date: February 2013

Study information

• Verified date: June 2015
• Source: University of Otago
• Contact: n/a
• Is FDA regulated: No
• Health authority: New Zealand: Health Research Council
• Study type: Interventional

Clinical Trial Summary

Aim

The purpose of this study is to evaluate whether fuel subsidies reduce exacerbations of COPD among people aged over 55, and therefore whether providing such subsidies is a cost-beneficial policy initiative.

The Warm Homes for Elder New Zealanders Study enrolled community-dwelling people aged over 55 with moderate or worse COPD. Prior to the study commencing the houses were insulated (if feasible, & the house-owner agreed). Data were collected on the health and energy use of the participants.

The households randomly assigned to the "early" intervention group had a subsidy to their power account their first winter in the study. The subsidy was the intervention and was designed to enable the participants, if they chose to do so, to keep their house warmer during the winter.

Description:

Warm Homes for Elder New Zealanders (WHEZ)

Background Although there has been considerable recent work on the prevention, management and causes of Chronic Obstructive Pulmonary Disease (COPD), the contribution of housing has not been well researched. This is despite the socio-economic patterning of COPD (Maori women have the highest rate of COPD that has been recorded for any group of women), and the relationship between socio-economic deprivation and housing conditions.

It is likely that improved heating would reduce exacerbations of COPD as:

• COPD patients with the most advanced disease tend to be older people who often live on a fixed income and may be unable to afford adequate heating

• There is a high excess of winter hospitalisations in COPD patients indicating COPD exacerbations may be triggered by cold conditions.

• About one third of exacerbations of COPD are triggered by respiratory infections.

• The Housing, Insulation and Health Study demonstrated a reduction in self-reported respiratory disease after houses were insulated. Therefore improving the heating in households with a COPD patient may reduce respiratory infections and this in turn would reduce the number and severity of exacerbations.

The percentage of people over 65 in New Zealand will increase from 12% to 22% over the next 25 years. Therefore it will become increasingly important to find cost-effective ways of reducing the morbidity of the older age group. As COPD is a significant cause of morbidity amongst older people, this study investigates a potentially cost effective intervention to reduce both the likelihood of expensive hospital stays and improve the quality of life for older people.

Aim To evaluate whether fuel subsidies reduce exacerbations of COPD among people aged over 55, and therefore whether providing such subsidies is a cost-beneficial policy initiative.

Potential Benefits The potential benefits of the study include reducing the burden of disease. The patients and their caregivers may experience improved quality of life. Hospitals may experience fewer patients requiring treatment during the winter. A cost-benefit analysis will quantify the benefits.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 522
• Est. completion date: February 2013
• Est. primary completion date: February 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 55 Years and older

Eligibility

Inclusion Criteria:

• Post Bronchodilator FEV1/FVC ratio < Lower Limit of Normal (NHanesIII)

• Post Bronchodilator FEV1 < 80% of the predicted FEV1 (NHanesIII)

OR - In the last three years either went to hospital for their COPD or took antibiotics/steriods for their COPD

Exclusion Criteria:

• Not planning to stay in the same dwelling until the end of the study

• Does not want to take part in research

• Unwilling to answer inclusion questionnaire

• Unable to communicate effectively

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Chronic Obstructive Pulmonary Disease
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Behavioral:
• Energy Voucher
Receive the intervention the first winter enrolled in the study. The intervention is a electricity voucher and a short pamphlet describing how to work out how much heat the voucher can buy.
• No intervention : control arm
Do not receive the money or pamphlet in the initial study year

Locations

Country	Name	City	State
New Zealand	Christchurch	Christchurch
New Zealand	Wanganui / Manawatu	Wanganui
New Zealand	Wellington / Hutt/ Porirua	Wellington

Sponsors (2)

Lead Sponsor	Collaborator
University of Otago	Health Research Council, New Zealand

Country where clinical trial is conducted

New Zealand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Moderate or severe exacerbations of COPD during winter for which hospitalisation, systemic corticosteroids and/or antibiotics are required to treat the exacerbation		Four months	No
Secondary	Severe exacerbations of COPD during winter for which hospitalisation is required to treat the exacerbation		Four months	No
Secondary	Moderate exacerbations of COPD during winter; which will be defined as requiring treatment with systemic corticosteroids and/or antibiotics		Four months	No
Secondary	All-cause hospitalisation during winter		Four months	No
Secondary	Temperature in the living and bedrooms during winter		Four months	No
Secondary	Electricity usage during winter		Four months	No
Secondary	Costs to health care system of index participant during winter		Four months	No
Secondary	Self-reported quality of life for index participant during winter		Four months	No
Secondary	Respiratory health of other people living in household during winter		Four months	No
Secondary	Any changes in index participant baseline lung function		course of study ( up to 18 months)	No
Secondary	Study withdrawals due to death or greater dependency		course of study (up to 18 months)	No
Secondary	Support person burden		course of study (up to 18 months)	No

External Links

•   Website for Housing and Health Research Programme